肝内胆管黏液腺癌与肝内胆管细胞癌的临床病理特征及预后分析

Clinicopathologic features and prognostic analysis of intrahepatic mucinous cholangiocarcinoma and intrahepatic cholangiocarcinoma

  • 摘要: 目的:探讨肝内胆管黏液腺癌(IMCC)与肝内胆管细胞癌(ICC)的临床病理特征及预后差异。方法:采用回顾性队列研究方法。收集2003年3月至2014年3月福建省立医院收治的20例IMCC和同期收治的51例ICC患者的临床病理资料。观察指标:(1)患者临床病理特征:性别,年龄,临床表现(发热、黄疸、腹痛、腹腔积液),术前实验室检查(ALT、AST、DBil、CEA、CA19-9、AFP),手术方式(根治性切除术、姑息性切除术),病理学特点(肿瘤部位、淋巴结转移、血管侵犯、病理学分期)。(2)随访情况(生存时间和1、3、5年生存率)。采用门诊及电话方式进行随访,观察患者生存情况。随访时间截至2015年 3月。正态分布的计量资料以±s表示,组间比较采用t检验。计数资料比较采用χ2检验。采用KaplanMeier法绘制生存曲线,Logrank检验进行生存分析。结果IMCC患者中发热、黄疸、AST升高、DBil升高、淋巴结转移、血管侵犯患者例数分别为13、11、10、11、3、1例,病理学分期0、Ⅰ、Ⅱ、Ⅲ、Ⅳ期例数分别为4、6、2、6、2例;ICC患者中发热、黄疸、AST升高、DBil升高、淋巴结转移、血管侵犯患者例数分别为12、10、9、2、22、36例,病理学分期0、Ⅰ、Ⅱ、Ⅲ、Ⅳ期例数分别为0、14、5、3、29例;上述指标两者比较,差异均有统计学意义(χ2= 10.830,8.639,7.672,25.059,8.036,24.765,26.601,P<0.05)。20例IMCC患者和51例ICC患者均获得随访,随访时间为1~118个月,中位随访时间为14个月。IMCC患者生存时间为(55±8)个月,1、3、5年生存率分别为94.4%、44.0%、16.7%。ICC患者生存时间为(30±6)个月,1、3、5年生存率分别为36.5%、12.5%、4.0%。两者生存情况比较,差异有统计学意义(χ2=8.126,P<0.05)。结论:IMCC比ICC患者 更易出现发热、黄疸等症状及肝功能损害,就诊时淋巴结转移和血管侵犯更少,病理学分期更早,远期预 后更好。

     

    Abstract: Objective:To investigate the clinicopathologic features and prognostic analysis of intrahepatic mucinous cholangiocarcinoma (IMCC) and intrahepatic cholangiocarcinoma (ICC). Methods:The retrospective cohort study was adopted. The clinicopathological data of 20 patients with IMCC and 51 patients with ICC who were admitted to the Fujian Provincial Hospital from March 2003 to March 2014 were collected. The observation indicators included (1) clinicopathologic features: gender, age, clinical symptoms (fever, jaundice, abdominal pain and peritoneal effusion), preoperative laboratory examination [alanine transaminase (ALT), aspartate transaminase (AST), direct bilirubin (DBil), carcinoembryonic antigen (CEA), CA19-9 and alphafetoprotein (AFP)], operation methods (radical resection, palliative resection) and pathological features (tumor location, lymph node metastasis, vascular invasion and pathological stage). (2) The followup of outpatient examination and telephone interview was performed to detect the survival of patients up to March 2015. Measurement data with normal distribution were represented as ±s and comparison between groups was analyzed using t test. Count data were analyzed using the chisquare test. The survival curve was drawn by KaplanMeier method, and the survival rate was analyzed using the Logrank test.
    ResultThe numbers of patients with fever,jaundice, elevated level of AST and DBil, lymph node metastasis, vascular invasion and numbers of patients with stage 0, Ⅰ, Ⅱ, Ⅲ, Ⅳ were 13, 11, 10, 11, 3, 1 and 4, 6, 2, 6, 2 with IMCC, 12, 10, 9, 2, 22, 36 and 0, 14, 5, 3, 29 with ICC, respectively, showing statistically significant differences in the above indicators (χ2=10.830, 8.639, 7.672, 25.059, 8.036, 24.765, 26.601, P<0.05). All the patients were followed up for a median time of 14 months (range, 1-118 months). The survival time and 1, 3, 5year survival rates were (55±8)months, 94.4%, 44.0%, 16.7% in 20 patients with IMCC and (30±6)months, 36.5%, 12.5%, 4.0% in 51 patients with ICC, respectively, showing a statistically significant difference (χ2=8.126, P<0.05). Conclusion:The patients with MICC are more easily complicated with fever, jaundice and liver dysfunction, while they have less lymph node metastasis and vascular invasion, earlier pathological stage and better prognosis compared with patients with ICC.

     

/

返回文章
返回